Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning
暂无分享,去创建一个
R. Rossaint | M. Coburn | A. Goetzenich | C. Stoppe | S. Kraemer | C. Beckers | Christian Bleilevens | Josefin Soppert | Christian Beckers | B. Mayer | S. Schemmel
[1] T. Loop,et al. Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4 , 2015, PloS one.
[2] T. Loop,et al. Neuroprotective effects of Argon are mediated via an ERK‐1/2 dependent regulation of heme‐oxygenase‐1 in retinal ganglion cells , 2015, Journal of neurochemistry.
[3] U. Goebel,et al. Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries? , 2015, Neural regeneration research.
[4] T. Loop,et al. Argon Inhalation Attenuates Retinal Apoptosis after Ischemia/Reperfusion Injury in a Time- and Dose-Dependent Manner in Rats , 2014, PloS one.
[5] R. Rossaint,et al. Argon: Systematic Review on Neuro- and Organoprotective Properties of an “Inert” Gas , 2014, International journal of molecular sciences.
[6] B. Liu,et al. [Effects of xenon preconditioning against ischemia/reperfusion injury and oxidative stress in immature heart]. , 2014, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.
[7] R. Rossaint,et al. Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening. , 2014, Resuscitation.
[8] Talicia Tarver,et al. HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .
[9] R. Autschbach,et al. The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes. , 2014, Interactive cardiovascular and thoracic surgery.
[10] R. Dickinson,et al. Neuroprotection against Traumatic Brain Injury by Xenon, but Not Argon, Is Mediated by Inhibition at the N-Methyl-D-Aspartate Receptor Glycine Site , 2013, Anesthesiology.
[11] R. Rossaint,et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. , 2013, British journal of anaesthesia.
[12] N. Roewer,et al. Endothelial nitric oxide synthase mediates the first and inducible nitric oxide synthase mediates the second window of desflurane-induced preconditioning. , 2013, Journal of cardiothoracic and vascular anesthesia.
[13] E. Nexo,et al. Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes , 2012, PloS one.
[14] Rolf Rossaint,et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. , 2012, European journal of pharmacology.
[15] G. Malik,et al. Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses , 2012, Acta anaesthesiologica Scandinavica.
[16] S. Hert. Cardioprotection by volatile anesthetics: what about noncardiac surgery? , 2011 .
[17] T. Vanden Hoek,et al. Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. , 2011, Biochimica et biophysica acta.
[18] R. Dickinson,et al. Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection , 2010, Critical care.
[19] M. Bönstrup,et al. Development of a Drug Screening Platform Based on Engineered Heart Tissue , 2010, Circulation research.
[20] M. Maze,et al. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells , 2010, Experimental biology and medicine.
[21] D. Yellon,et al. The Second Window of Preconditioning (SWOP) Where Are We Now? , 2010, Cardiovascular Drugs and Therapy.
[22] M. Maze,et al. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion , 2010, Neuroscience.
[23] R. Rossaint,et al. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury , 2009, Critical care.
[24] M. Maze,et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury , 2009, Neuroscience Letters.
[25] M. Maze,et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. , 2009, Journal of the American Society of Nephrology : JASN.
[26] Z. Bosnjak,et al. Xenon Preconditioning: The Role of Prosurvival Signaling, Mitochondrial Permeability Transition and Bioenergetics in Rats , 2009, Anesthesia and analgesia.
[27] W. Schlack,et al. Xenon Induces Late Cardiac Preconditioning In Vivo: A Role for Cyclooxygenase 2? , 2008, Anesthesia and analgesia.
[28] J. Schaper,et al. Mechanical load induced by glass microspheres releases angiogenic factors from neonatal rat ventricular myocytes cultures and causes arrhythmias , 2008, Journal of cellular and molecular medicine.
[29] P. Pagel,et al. Noble Gases Without Anesthetic Properties Protect Myocardium Against Infarction by Activating Prosurvival Signaling Kinases and Inhibiting Mitochondrial Permeability Transition In Vivo , 2007, Anesthesia and analgesia.
[30] D. Yellon,et al. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection , 2007, Heart Failure Reviews.
[31] D. Vaux,et al. Error bars in experimental biology , 2007, The Journal of cell biology.
[32] W. Schlack,et al. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. , 2006, British journal of anaesthesia.
[33] N. Maulik,et al. Cardiac genomic response following preconditioning stimulus. , 2006, Cardiovascular research.
[34] S. D. De Hert. Volatile anesthetics and cardiac function. , 2006, Seminars in cardiothoracic and vascular anesthesia.
[35] W. Schlack,et al. Mechanisms of xenon‐ and isoflurane‐induced preconditioning – a potential link to the cytoskeleton via the MAPKAPK‐2/HSP27 pathway , 2005, British journal of pharmacology.
[36] P. Cumming,et al. Pig brain stereotaxic standard space: Mapping of cerebral blood flow normative values and effect of MPTP-lesioning , 2005, Brain Research Bulletin.
[37] H. Otani,et al. Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart. , 2005, American journal of physiology. Heart and circulatory physiology.
[38] Frank J Giordano,et al. Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.
[39] Seng H. Cheng,et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. , 2005, American journal of physiology. Cell physiology.
[40] W. Schlack,et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC‐ɛ and p38 MAPK , 2005, British Journal of Pharmacology.
[41] B. Meyrick,et al. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium , 2004, Laboratory Investigation.
[42] F. Hartl,et al. Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.
[43] J. Downey,et al. Preconditioning the myocardium: from cellular physiology to clinical cardiology. , 2003, Physiological reviews.
[44] Q. Feng,et al. Delayed preconditioning in cardiac myocytes with respect to development of a proinflammatory phenotype: role of SOD and NOS. , 2003, Cardiovascular research.
[45] K. Bitar. HSP27 phosphorylation and interaction with actin-myosin in smooth muscle contraction. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[46] M. Gray,et al. Sensitive determination of cell number using the CyQUANT cell proliferation assay. , 2001, Journal of immunological methods.
[47] P. Pagliaro,et al. Ischemic preconditioning: from the first to the second window of protection. , 2001, Life sciences.
[48] R. Bolli,et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. , 2000, American journal of physiology. Heart and circulatory physiology.
[49] Guido Kroemer,et al. Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.
[50] P. Ping,et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Dietz,et al. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. , 1999, Circulation.
[52] M. Hess,et al. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. , 1999, Circulation.
[53] R. Morimoto,et al. Regulation of the Heat Shock Transcriptional Response: Cross Talk between a Family of Heat Shock Factors, Molecular Chaperones, and Negative Regulators the Heat Shock Factor Family: Redundancy and Specialization , 2022 .
[54] Jody L. Martin,et al. Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. , 1998, American journal of physiology. Heart and circulatory physiology.
[55] A. Giaccia,et al. Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis* , 1998, The Journal of Biological Chemistry.
[56] R. Bolli,et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. , 1997, Circulation research.
[57] J. Downey,et al. Infarct limitation of the second window of protection in a conscious rabbit model. , 1996, Cardiovascular research.
[58] M. Ashraf,et al. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. , 1996, Circulation.
[59] U. Förstermann,et al. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. , 1995, Biochemical pharmacology.
[60] K. Nakao,et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.
[61] D. Yellon,et al. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? , 1995, Journal of molecular and cellular cardiology.
[62] M. Hori,et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. , 1994, The Journal of clinical investigation.
[63] H. Weiss,et al. EFFECT OF INCREASED MYOCARDIAL CYCLIC GMP INDUCED BY CYCLIC GMP‐PHOSPHODIESTERASE INHIBITION ON OXYGEN CONSUMPTION AND SUPPLY OF RABBIT HEARTS , 1994, Clinical and experimental pharmacology & physiology.
[64] R. Kennedy,et al. Anaesthesia and the ‘Inert’ Gases with Special Reference to Xenon , 1992, Anaesthesia and intensive care.
[65] W. Welch,et al. Heat Shock Protein Induction in Rat Hearts: A Role for Improved Myocardial Salvage After Ischemia and Reperfusion? , 1992, Circulation.
[66] V. Sukhatme,et al. Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. , 1990, The Journal of biological chemistry.
[67] D. Gerlier,et al. Use of MTT colorimetric assay to measure cell activation. , 1986, Journal of immunological methods.
[68] S. D. De Hert. Cardioprotection by volatile anesthetics: what about noncardiac surgery? , 2011, Journal of cardiothoracic and vascular anesthesia.
[69] R. Gottlieb,et al. Heart mitochondria: gates of life and death. , 2008, Cardiovascular research.
[70] W. Schlack,et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. , 2005, British journal of pharmacology.
[71] A. Fedotov,et al. [Survival of laboratory animals in argon-containing hypoxic gaseous environments]. , 1998, Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine.
[72] Soldatov Pe,et al. [Survival of laboratory animals in argon-containing hypoxic gaseous environments]. , 1998 .
[73] D. Latchman,et al. The molecular basis of adaptation to ischemia in the heart: the role of stress proteins and anti-oxidants in the ischemic and reperfused heart. , 1996, EXS.
[74] Keiichiro Suzuki,et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. , 1993, The American journal of physiology.